What Difference Does a Diagnosis Make? Evidence from Marginal Patients

IF 3.1 2区经济学 Q1 ECONOMICS

American Journal of Health Economics Pub Date : 2023-01-26 DOI:10.1086/724415

Mattan Alalouf, Sarah Miller, Laura R Wherry

引用次数: 1

Abstract

Next article No AccessWhat Difference Does a Diagnosis Make? Evidence from Marginal PatientsMattan Alalouf, Sarah Miller, and Laura R WherryMattan Alalouf Search for more articles by this author , Sarah Miller Search for more articles by this author , and Laura R Wherry Search for more articles by this author PDFPDF PLUS Add to favoritesDownload CitationTrack CitationsPermissionsReprints Share onFacebookTwitterLinkedInRedditEmail SectionsMoreDetailsFiguresReferencesCited by American Journal of Health Economics Just Accepted Published for the American Society of Health Economists (ASHEcon) Article DOIhttps://doi.org/10.1086/724415 Views: 8Total views on this site HistoryAccepted January 25, 2023 © 2023 American Society of Health Economics. All Rights reserved.PDF download Crossref reports no articles citing this article.

查看原文本刊更多论文

诊断有什么区别?来自边缘患者的证据

下一篇文章无法访问诊断有什么区别?来自边缘病人的证据mattan Alalouf, Sarah Miller和Laura R WherryMattan Alalouf搜索这个作者的更多文章，Sarah Miller搜索这个作者的更多文章，和劳拉R摆渡船寻找更多的文章作者PDFPDF +添加favoritesDownload CitationTrack CitationsPermissionsReprints分享onFacebookTwitterLinkedInRedditEmail SectionsMoreDetailsFiguresReferencesCited通过美国卫生经济学杂志接受出版的美国社会卫生经济学家(ASHEcon)文章DOIhttps: / / doi.org/10.1086/724415视图:8总意见这个网站HistoryAccepted 1月25日,2023年©2023年美国社会卫生经济学。Crossref报告没有引用这篇文章的文章。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

American Journal of Health Economics Multiple-

CiteScore

4.30

自引率

2.70%

发文量

期刊介绍： The American Journal of Health Economics (AJHE) provides a forum for the in-depth analysis of health care markets and individual health behaviors. The articles appearing in AJHE are authored by scholars from universities, private research organizations, government, and industry. Subjects of interest include competition among private insurers, hospitals, and physicians; impacts of public insurance programs, including the Affordable Care Act; pharmaceutical innovation and regulation; medical device supply; the rise of obesity and its consequences; the influence and growth of aging populations; and much more.